Search research articles
Contact Us
Filters
Showing results (161-170 of 176) with videos related to
Page
of 18
Sort By:
Transplantation and Cellular Therapy
|
June 6, 2023
Phase II, Open-Label Clinical Trial of Urinary-Derived Human Chorionic Gonadotropin/Epidermal Growth Factor for Life-Threatening Acute Graft-versus-Host Disease
Shernan G Holtan, Andrea Hoeschen, Qing Cao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 15, 2018
Amphiregulin in intestinal acute graft-versus-host disease: a possible diagnostic and prognostic aid
Khalid Amin, Usman Yaqoob, Brittney Schultz, et al.
Bone Marrow Transplantation
|
January 9, 2021
Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant
Grigori Okoev, Daniel J Weisdorf, John E Wagner, et al.
JCI Insight
|
December 8, 2017
Glycolytic requirement for NK cell cytotoxicity and cytomegalovirus control
Annelise Y Mah, Armin Rashidi, Molly P Keppel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 5, 2018
Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-Up
Erica Dahl Warlick, Todd E DeFor, Nelli Bejanyan, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 10, 2023
Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in GVHD Risk Without Increased Relapse Risk Compared to Historical Cyclosporine/Methotrexate
Najla El Jurdi, Alex Hoover, Daniel O'Leary, et al.
Transplantation and Cellular Therapy
|
June 13, 2023
Phase II Study of Myeloablative 7-8/8-Matched Allotransplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil
Najla El Jurdi, Alex Hoover, Daniel O'Leary, et al.
American Journal of Hematology
|
October 7, 2016
Reduced intensity conditioned allograft yields favorable survival for older adults with B-cell acute lymphoblastic leukemia
Ashley Rosko, Hai-Lin Wang, Marcos de Lima, et al.
Blood Cancer Journal
|
May 19, 2021
High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group
Najla El Jurdi, Heba Elhusseini, Joan Beckman, et al.
Cancer
|
January 25, 2017
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis
Fotios V Michelis, Vikas Gupta, Mei-Jie Zhang, et al.
Page
of 18
Search research articles
Search
Showing results (161-170 of 176) with videos related to
Sort By:
Page
of 18
Transplantation and Cellular Therapy
|
June 6, 2023
Phase II, Open-Label Clinical Trial of Urinary-Derived Human Chorionic Gonadotropin/Epidermal Growth Factor for Life-Threatening Acute Graft-versus-Host Disease
Shernan G Holtan, Andrea Hoeschen, Qing Cao, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
November 15, 2018
Amphiregulin in intestinal acute graft-versus-host disease: a possible diagnostic and prognostic aid
Khalid Amin, Usman Yaqoob, Brittney Schultz, et al.
Bone Marrow Transplantation
|
January 9, 2021
Outcomes of chronic graft-versus-host disease following matched sibling donor versus umbilical cord blood transplant
Grigori Okoev, Daniel J Weisdorf, John E Wagner, et al.
JCI Insight
|
December 8, 2017
Glycolytic requirement for NK cell cytotoxicity and cytomegalovirus control
Annelise Y Mah, Armin Rashidi, Molly P Keppel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
August 5, 2018
Reduced-Intensity Conditioning Followed by Related and Unrelated Allografts for Hematologic Malignancies: Expanded Analysis and Long-Term Follow-Up
Erica Dahl Warlick, Todd E DeFor, Nelli Bejanyan, et al.
Medrxiv : the Preprint Server for Health Sciences
|
April 10, 2023
Phase II Study of Myeloablative 8/8- or 7/8-Matched Allotransplantation with Post-Transplant Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil: Marked Reduction in GVHD Risk Without Increased Relapse Risk Compared to Historical Cyclosporine/Methotrexate
Najla El Jurdi, Alex Hoover, Daniel O'Leary, et al.
Transplantation and Cellular Therapy
|
June 13, 2023
Phase II Study of Myeloablative 7-8/8-Matched Allotransplantation with Post-Transplantation Cyclophosphamide, Tacrolimus, and Mycophenolate Mofetil
Najla El Jurdi, Alex Hoover, Daniel O'Leary, et al.
American Journal of Hematology
|
October 7, 2016
Reduced intensity conditioned allograft yields favorable survival for older adults with B-cell acute lymphoblastic leukemia
Ashley Rosko, Hai-Lin Wang, Marcos de Lima, et al.
Blood Cancer Journal
|
May 19, 2021
High incidence of thromboembolism in patients with chronic GVHD: association with severity of GVHD and donor-recipient ABO blood group
Najla El Jurdi, Heba Elhusseini, Joan Beckman, et al.
Cancer
|
January 25, 2017
Cytogenetic risk determines outcomes after allogeneic transplantation in older patients with acute myeloid leukemia in their second complete remission: A Center for International Blood and Marrow Transplant Research cohort analysis
Fotios V Michelis, Vikas Gupta, Mei-Jie Zhang, et al.
Page
of 18